Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
F134784-250mg | 250mg | In stock | $15.90 | |
F134784-1g | 1g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $41.90 | |
F134784-5g | 5g | In stock | $162.90 |
ROCK2 inhibitor
Synonyms | Fasudil|103745-39-7|ha-1077|HA 1077|AT 877|HA1077|Fasudil [INN]|Fasudilum|1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)-|AT-877|1-(5-Isoquinolinesulfonyl)homopiperazine|5-(1,4-diazepan-1-ylsulfonyl)isoquinoline|5-(1,4-diazepane-1-sulfonyl)isoqui |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Rho-associated protein kinase inhibitor |
ALogP | 1 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 5-(1,4-diazepan-1-ylsulfonyl)isoquinoline |
---|---|
INCHI | InChI=1S/C14H17N3O2S/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14/h1,3-5,7,11,15H,2,6,8-10H2 |
InChi Key | NGOGFTYYXHNFQH-UHFFFAOYSA-N |
Canonical SMILES | C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3 |
Isomeric SMILES | C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3 |
PubChem CID | 3547 |
Molecular Weight | 291.37 |
CAS Registry No. | 103745-39-7 |
---|---|
Wikipedia | Fasudil |
PubChem CID | 3547 |
ChEMBL Ligand | CHEMBL38380 |
RCSB PDB Ligand | M77 |
PEP | fasudil |
DrugCentral Ligand | 1132 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E2422096 | Certificate of Analysis | May 11, 2024 | F134784 |
H2206724 | Certificate of Analysis | May 11, 2024 | F134784 |
H2206584 | Certificate of Analysis | May 09, 2024 | F134784 |
B2429020 | Certificate of Analysis | Jun 15, 2022 | F134784 |
H2206723 | Certificate of Analysis | Jun 15, 2022 | F134784 |
H2303098 | Certificate of Analysis | Jun 15, 2022 | F134784 |
L2307083 | Certificate of Analysis | Jun 15, 2022 | F134784 |
Solubility | Soluble in DMSO |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
1. Huentelman MJ, Stephan DA, Talboom J, Corneveaux JJ, Reiman DM, Gerber JD, Barnes CA, Alexander GE, Reiman EM, Bimonte-Nelson HA. (2009) Peripheral delivery of a ROCK inhibitor improves learning and working memory.. Behav Neurosci, 123 (1): (218-23). [PMID:19170447] |
2. Doggrell SA. (2005) Rho-kinase inhibitors show promise in pulmonary hypertension.. Expert Opin Investig Drugs, 14 (9): (1157-9). [PMID:16144499] |
3. Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, Suzuki Y, Hidaka H. (1989) Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase.. Br J Pharmacol, 98 (4): (1091-100). [PMID:2611484] |
4. Shibuya M, Suzuki Y. (1993) [Treatment of cerebral vasospasm by a protein kinase inhibitor AT 877].. No To Shinkei, 45 (9): (819-24). [PMID:8217408] |